 Okay, today we're going to go through the top three penny stocks to buy now and some of these, I think could actually grow up to 500% will go through these penny stocks and the information for these penny stocks. I'm going to say I'm not a financial advisor. I am a business teacher in my daily life, but I'm by no means an expert on the stock market. And some of these penny stocks have had a little bit of a pullback, which is presenting a bit more of a buying opportunity because a lot of the penny stocks at the moment with the market have actually moved up a lot. So I'm looking for ones that have a bit of a pullback but still have a lot of potential as a company. And we'll go through some of these penny stocks and what these are as well. I'll go through that in this video. Okay, so let's get right into it. If we could leave a like on the video and if you appreciate the direct approach of getting right into the penny stocks, then do leave a like that we much appreciate. Let's get into the information. So the first stock we've got is IQSTEL. Okay, so IQSTEL. Six symbol for this is IQST. Okay, one of the good points about this stock is we'll go into what they do. But first of all, you know, look at the sort of revenue they're looking to get 60.5 million revenue forecast for 2021, 48.8 million revenue from the preliminary for 2020. They've got a 60% prepaid revenue already. They're in 13 in country presence. They've got seven operating subsidiaries. So this is an interesting company will go into what they do, but financially it seems they're doing okay. There is a bit of an issue with their liabilities, how much cost in terms of the liabilities that they have. So hopefully they can reduce those a little bit. But we'll go into what they do. So first of all, IQSTEL, which is six symbol IQST, is a US based publicly traded company offering leading edge telecommunications and technology services for global markets. Okay, and this is an interesting one. They're involved in a bit of blockchain or involved in fintech. You know, they've got B2B in terms of business to business customers. And then also got B2C in terms of business to customers, and you've got B2B in terms of business to business, right? So they've got different divisions telecom, technology, technology, fintech and blockchain, all areas which are emerging markets and growing industries, right, which is good to see. Now the current price on this stock here with the ticker symbol IQST, at least on the OTC of the counter markets here, is the current price is at 0.76. It has a little bit of a dip recently. Okay, so it's moved down from its previous highs here. So it's moved down a bit. This is presenting a buying opportunity. Again, it's involved in a lot of emerging industries. I like to look at penny stocks that are involved in industries where I see that there's been a massive potential market. So this is potentially one to put on your radar. Now just want to remind everybody to turn on the notifications if you haven't already and welcome to the channel if you're new. We cover many penny stocks and a range of different ones. So do subscribe if you're new to the channel and leave a like on the video so it gets up into the YouTube search results as well. Okay, let's go through the next one. The next one we're going to talk about is Vine, which is a ticker symbol, V-Y-N-E, and this is Vine Therapeutics. And they're involved in basically improving patient lives by working to develop innovations in dermatology and beyond. So they've got some creams available that are basically good for particular skin conditions, right? And it's involved in that particular area in terms of skincare and actually producing really good medical solutions for this. And the best part about this stock, V-Y-N-E, okay, is that it's actually already been FDA approved on not just one product, right? They've been FDA approved on two products here. So what does that mean? It means they're at their commercialization stage, they're getting that commercialization, they're getting the products out there, they're getting the sales out, right? So again, I'm not going to go fully in depth in the stock because it's just a top list. I'm just putting some on your radar. You can do further research into this. But the key point here is that they're FDA approved. I mean, we've seen other pharmaceutical stocks that are yet to be FDA approved actually shoot up more than this is the current price that this is at. And they haven't even got FDA approval yet. And maybe the very good stock, some of those as well, by the way, but going into this, these are FDA approved. So they have already got their commercialization, right? So they're commercializing their products. They're getting ready to commercialize and build that commercialization up, which is fantastic. And then they've got this other area here where they're actually putting more products in the pipeline to get FDA approved. Now, they've already got history of being able to get FDA approved on products, which is kind of gives it a good kind of confidence that other products that they come out with can also do the same, right? So the current price for this, by Therapeutics, tick symbol, VYNE is at $2.94. It's again, had a tiny bit of a pullback, not much because this one just kind of keeps running up. It has a bit of a pullback keeps running up. You know, it may pull back to sort of 250 to 270, but I think it's got more of a chance to keep running up, right? And you've got the stock analyst forecast, seven analysts, CNN business, they've got a lower $3, a medium of $6 and a high of $10. Okay. And it's currently at $2.94. Now, I believe that it could hit between this medium and high estimate, I think that it could easily get to $7, $8, $9, $10. You know, move up hundreds of percentage points here from its current price point, 240% potentially on its current price point, right? I think that's got potential to do that, especially if they continue to commercialize the product and start to get more revenue in, because then they've got that revenue to then invest back into the business and create more products and then commercialize even more and build a massive product portfolio. So this one's got a lot of potential. It's got an interest in future ahead of it, I think, at least in the medium term. Okay. So this is one, again, a little bit of a pullback, maybe start a small position up to you. I'm not a financial advisor, you do your own research, but you know, it's pulling back a little bit, okay, which is good, might pull back a bit more and then it might be buying opportunity. Now, the next one we're going to talk about is SG blocks, ticker symbol for this is SGBX. Now, I've covered this on the channel before and it has run up from the time that I covered it, and I think that it's going to run up even further, but recently it has had a bit of a pullback and I actually think that this is again presenting a buying opportunity. I'm giving you stocks that have had a bit of a pullback because the market is doing very well at the minute, so a lot of penny stocks are making moves. So I'm trying to find ones that are kind of either consolidating and have consolidated for a while or have moved down a little bit. So this stock creates basically, it takes canisters, containers, if you like, and it turns them into commercial, the container into houses, the container into commercial residents, like for example, Starbucks, they've done stuff with Starbucks in terms of creating mini cafes out of what they do in terms of the containers. So there's a lot of business to business sales that they could get from this. But recently, this is what they've been doing recently, which could be a catalyst to move in the stock price up even further in the short to medium term, but then in the long term, they've got this whole business model that is really, really good. Think about the facts that, you know, brick and mortar stores, the cost of rent, it costs a lot of money. So if this business is coming in there offering a solution to small businesses and to larger business to cut their operations costs by using these containers, but still being really good quality, then this has got a good, really good value proposition as a business, right? I really do believe in this one. I'm actually bought into this one myself. I really do like this one, SGBX. But what is the recent catalysts? What kind of brewing right now? Okay. Actually, SGA blocks has just recently announced February to provide testing services to KLM Royal Dutch Airlines. Okay. So a leading designer, innovator and fabricator of fabricator of container based structures announced today that it will offer travelers a rapid anti-gen testing at Los Angeles International Airport for that clarity, mobile ventures, the joint endeavor between SGA blocks and clarity diagnostics. Okay. So they're actually building these containers that can be built in a very fast time, right? These containers, these can be set up. They can build up, you know, really, really fast, which are really efficient to build and they can just really build them very, very fast. You know, this could be a catalyst in the fact that more of these sort of testing centers could be set up through SGA block SGBX or, you know, even potential vaccine centers as well, right? So if they can, more of this comes out, if more of this comes out, you know, and bigger, bigger contracts, this could be big for the stock. And this is asleep. But not many people are talking about this. Okay. So put this on your radar, right? Also recently, it happened in January, right? It happened here. So they're bringing anti-gen testing to Chicago. So it says here, in terms of the Chicago area, to bring rapid COVID-19 test to Chicago, area travel that travelers airport employees and the public at large, right? So they're bringing it there as well, which is interesting. This is something that they seem to be scaling up. Now, of course, this is only necessarily going to have an impact on the short to medium term capacity for 10,000 tested. Look, this is to the short to medium term, right? Because we are sort of eventually, you know, moving out of this kind of situation. But I think that this in short to medium term, it's going to push the stock price up if this keeps happening. But then beyond that, I think, you know, I think the long term approach of what the business offers overall, I think is really good as well. So there's two ways you can play it by doing things potential, right? What's current price? $7 for ticker symbol SGBX. Like the video if you're enjoying this by the way. So what we got, $7 and four, you can see here, $8. Now, you know, it was almost $9. It's 52 week highs, $9.74. It did run up. We might say $1.16 is because it had a run up over the past few months. But it's now starting to pull back a little bit. And then it's kind of consolidating a little bit. But what I would say is, you know, as it's because it's pulled back here to the $7 level from the $9.74, it could be a really good time to potentially start a position. You do your own research. It's up to you what you do. But consider starting this. And then, you know, start building a position. If it dips to six or five, keep loading up. And I think this is going to easily, you know, move up much further than this current level by a huge amount. Okay. Thanks for watching the video. Do leave the video a like. It does help out the channel. Subscribe if you're new. Welcome. Cover penny stocks and all sorts of stuff. And I will see everybody in the next one.